Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
425 studies found for:    Open Studies | "Ovarian Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Cabazitaxel vs. Tocotrienol in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.
Condition: Ovarian Cancer
Interventions: Drug: Cabazitaxel;   Drug: Tocotrienol
22 Recruiting EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel + Carboplatin every 3 weeks;   Drug: Carboplatin monotherapy every 3 weeks;   Drug: Weekly Paclitaxel and Carboplatin
23 Recruiting Study of Predictive Factors of Chemoresistance in Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: Cancer treatment
24 Recruiting Mesenchymal Stem Cells (MSC) for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: MSC-INFβ;   Behavioral: Questionnaires
25 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: OMP-54F28, Paclitaxel and Carboplatin
26 Recruiting Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
27 Recruiting Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Conditions: Ovarian Cancer;   Metastatic Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pembrolizumab
28 Recruiting C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population
Condition: Ovarian Cancer, Hereditary Ovarian Cancer Syndrome
Intervention:
29 Recruiting Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer
Condition: Recurrent Ovarian Cancer
Intervention: Drug: Nuc-1031 and Carboplatin
30 Recruiting Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
31 Recruiting HE4 as a Relapse Biomarker in Ovarian Cancers
Condition: Ovarian Carcinoma
Intervention: Other: Experimental arm
32 Recruiting CT Antigen TCR-redirected T Cells for Ovarian Cancer.
Condition: Ovarian Cancer
Intervention: Biological: NYESO-1c259 T cells
33 Recruiting Institut Paoli Calmettes Ovarian Cancer Database
Condition: Ovarian Neoplasms
Intervention: Other: Data collection
34 Recruiting Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer
Condition: Recurrent Ovarian Cancer
Intervention: Drug: LDE225
35 Recruiting Niraparib and/or Niraparib-Bevacizumab Combination Against Bevacizumab Alone in HRD Platinum Sensitive Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Niraparib;   Drug: Bevacizumab
36 Recruiting Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Procedure: Cytoreductive Surgery and HIPEC;   Procedure: CRS alone
37 Not yet recruiting Cost Utility of Radical Surgery in Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: Collection of additional data with questionnaires
38 Recruiting A Study of Niraparib Maintenance Treatment in Patients With HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Condition: Ovarian Cancer
Interventions: Drug: Niraparib;   Drug: Placebo
39 Recruiting Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: PDS;   Drug: 6 cycles of standard chemotherapy;   Drug: 3 cycles of standard NACT;   Procedure: IDS;   Drug: 3 cycles of standard chemotherapy
40 Recruiting PTX-200 and Carboplatin in Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Triciribine;   Drug: Carboplatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.